SWA
ABBV icon

Strata Wealth Advisors’s AbbVie ABBV Stock Holding History

Strata Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$453K Buy
1,802
+147
+9% +$31.6K 0.11% 58
2026
Q1 		$360K Sell
1,655
-25
-1% -$5.55K 0.1% 61
2025
Q4 		$384K Buy
1,680
+36
+2% +$8.2K 0.11% 57
2025
Q3 		$381K Buy
1,644
+275
+20% +$56K 0.1% 68
2025
Q2 		$254K Buy
1,369
+154
+13% +$28.6K 0.07% 70
2025
Q1 		$255K Sell
1,215
-295
-20% -$57.3K 0.08% 64
2024
Q4 		$268K Buy
+1,510
New +$278K 0.08% 70
2024
Q2 		– Sell
-2,315
Closed -$422K – 76
2024
Q1 		$422K Buy
+2,315
New +$399K 0.15% 51

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Strata Wealth Advisors's ABBV Position: Q2 2026 in Review

Strata Wealth Advisors increased its AbbVie (ABBV) stake by 8.9% in Q2 2026, buying an estimated $31.6K and bringing the position to 1,802 shares worth $453K. The position accounts for 0.11% of the portfolio, ranked #58.

Strata Wealth Advisors first reported a position in ABBV in Q1 2024 and has held it in 8 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Strata Wealth Advisors held 1,802 shares of AbbVie worth $453K as of Q2 2026.
  • Strata Wealth Advisors bought 147 AbbVie shares in Q2 2026, an estimated $31.6K.
  • AbbVie made up 0.11% of Strata Wealth Advisors's portfolio in Q2 2026, its #58 holding.
  • Strata Wealth Advisors first reported a position in AbbVie in Q1 2024 and has held it in 8 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Strata Wealth Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.